Swedish Mega-Study scans 1,400 for clues to heart, lung, and liver disease

NCT ID NCT07476703

Recruiting now Knowledge-focused Sponsor: Danderyd Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is re-examining 1,400 adults in Stockholm to find early signs and risk factors for heart, lung, and liver diseases. Participants will get advanced scans, blood tests, and questionnaires. The goal is to better understand how these diseases develop and how to predict them.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could improve early detection and risk prediction for heart, lung, and liver diseases, potentially guiding future prevention strategies.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic aneurysm Aortic Valve Disease aortic valve disorder chronic obstructive pulmonary disease congenital mitral valve insufficiency and/or stenosis COPD, severe early onset coronary artery disorder Dyslipidemias fatty liver disease heart failure Inflammation lung disorder metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC VALVE DISEASES ARTERIAL STIFFNESS, BLOOD PRESSURE CORONARY ARTERY DISEASE HEART FAILURE INFLAMMATION BIOMARKERS LIPID PROFILE MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE METABOLIC ASSOCIATED-DYSFUNCTION STEATOHEPATITIS (MASH) MITRAL VALVE STENOSIS AND/OR INSUFFICIENCY ORAL MICROBIOTA PULMONARY DISEASE, CHRONIC OBSTRUCTIVE (COPD) STEATOHEPATITIS

Contacts and locations

Locations

Cardiovascular Research Lab, Dept Cardiology, Danderyd University Hospital
RECRUITING

Stockholm, 18288, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.